About Raymond Silverman
Raymond C. Silverman is a Partner at Parker Waichman LLP in New York. He joined the firm as an Associate in August 2004 and became a Partner in January 2011. He has been a member of the New York Bar since April 2000 and is admitted to practice in the U.S. District Courts for the Southern, Eastern, Western, and Northern Districts of New York. Over his more than twenty-one years of practice, he has handled general negligence, medical malpractice, and products liability litigation in New York State courts, and for the past decade has focused on representing plaintiffs in multidistrict and complex litigation.
He has served as lead trial counsel in medical device cases, taken the depositions of senior corporate representatives in pharmaceutical and device companies, and worked with experts across disciplines ranging from orthopedics and epidemiology to biostatistics. He has served as Co-Lead Counsel in In Re: Mirena IUD Products Liability Litigation and currently serves as Co-Lead Counsel in In Re Tasigna Products Liability Litigation (MDL 3006), and as a member of the Plaintiffs' Steering Committee in In Re: Davol/C.R. Bard Hernia Mesh Multi-Case Management.
Proven verdicts and settlements at Parker Waichman LLP
These results are credited to Parker Waichman LLP. A result appears under an attorney's own name only when a published source names them as counsel on the case.
A Nassau County jury found on June 26, 2025 that South Shore Rehabilitation and Nursing Center in Freeport violated the Public Health Law and was negligent in caring for resident Henry Serrapica, who developed pressure ulcers on his heels, ankle and sacral area during 2019 and died that December. The jury awarded $5 million, including $1 million in punitive damages. In January 2026 the trial court denied the defense motions to set the verdict aside, reduce it or order a new trial, and the case then went to the Appellate Division.
A Richmond County jury awarded $1,102,000 to the family of a 73-year-old woman with Alzheimer's disease who fell at a Staten Island nursing facility and died weeks later; the Appellate Division reversed the judgment in 2020 and ordered a new trial.
In early 2014, Biomet agreed to pay at least $56 million to settle about 1,000 federal lawsuits over its M2a 38 and M2a Magnum metal-on-metal hip implants, consolidated in the Northern District of Indiana. Qualifying patients who had the device revised received a base award of $200,000, adjusted by individual factors. Thomas Anapol was court-appointed Co-Lead Counsel with W. Mark Lanier and signed the agreement for the Plaintiffs' Executive Committee. The figure covers many unrelated plaintiffs, is a reported minimum rather than a final total, and is not itemized by person.
Prior results do not guarantee a similar outcome. Each case is unique and depends on its own facts.
